Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.68 |
| ▸ | F3 | P13726 | 2/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.68 |
| ▸ | ESR1 | P03372 | 3/20 | 0.65 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | CA3 | P07451 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 1/20 | 0.65 |
| ▸ | CA6 | P23280 | 1/20 | 0.65 |
| ▸ | DPP4 | P27487 | 1/20 | 0.65 |
| ▸ | CA5A | P35218 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL214615 | 1.00 | TYR (0.68) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1450230 | 0.91 | F3 (0.52) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL7558225 | 0.82 | CYP1B1 (0.53) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL7558227 | 0.82 | CYP1B1 (0.53) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL3580956 | 0.81 | TYR (1.00) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL2198475 | 0.81 | TYR (1.00) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL2146080 | 0.81 | TYR (1.00) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL12426066 | 0.80 | PELI1 (0.44) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL8147578 | 0.80 | CYP1A2 (0.69) | MAOBCYP3A4KMT2ARAB9AMMP1 | |
| SCHEMBL14941432 | 0.80 | ALDH1A1 (0.48) | TYRF3CYP2D6CYP2C9HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240191245-A1 | PLANT CELL MATRICES AND METHODS THEREOF | CALYXT, INC. (US) | 2024-06-13 | — | — | US | claimed |
| WO-2022198085-A2 | PLANT CELL MATRICES AND METHODS THEREOF | CALYXT, INC. (US) | 2022-09-22 | — | — | WO | claimed |
| CN-110907575-B | Deep annotation method of hydroxycinnamic acid amide in plants | 中国科学院大连化学物理研究所 | 2021-10-08 | — | — | CN | claimed |
| CN-110907575-A | Deep annotation method of hydroxycinnamic acid amide in plants | 中国科学院大连化学物理研究所 | 2020-03-24 | — | — | CN | claimed |
| EP-0255695-B1 | P-HYDROXYCINNAMAMIDE DERIVATIVES AND MELANIN INHIBITOR COMPRISING THE SAME | Kao Corporation (JP) | 1991-06-12 | — | — | EP | claimed |
| US-4981680-A | P-hydroxycinnamamide derivatives and melanin inhibitor comprising the same | KAO CORPORATION (JP) | 1991-01-01 | — | — | US | claimed |
| US-4876084-A | FOR SPOTS, FRECKLES AND SUNBURN | KAO CORPORATION (JP) | 1989-10-24 | — | — | US | claimed |
| EP-0255695-A2 | p-Hydroxycinnamamide derivatives and melanin inhibitor comprising the same | Kao Corporation (JP) | 1988-02-10 | — | — | EP | claimed |
| JP-57046915-A | — | — | None | — | — | JP | disclosed |
| JP-60190713-A | — | — | None | — | — | JP | disclosed |
| US-20260091612-A1 | PRINTING INTAGLIO PLATE AND PRODUCTION METHOD THEREOF, AND PRINTING METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-04-02 | — | — | US | disclosed |
| CN-121108220-A | Imidazole-4-ethylamine-p-hydroxycinnamamide-1-N-beta-D-glucoside as well as preparation method and application thereof | 泰州学院 | 2025-12-12 | — | — | CN | disclosed |
| CN-121108220-A | Imidazole-4-ethylamine-p-hydroxycinnamamide-1-N-beta-D-glucoside as well as preparation method and application thereof | 泰州学院 | 2025-12-12 | — | — | CN | disclosed |
| EP-4631736-A1 | PRINTING INTAGLIO PLATE AND PRODUCTION METHOD THEREFOR, AND PRINTING METHOD | Asahi Kasei Kabushiki Kaisha (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-4876084-A | FOR SPOTS, FRECKLES AND SUNBURN | KAO CORPORATION (JP) | 1989-10-24 | — | — | US | disclosed |
| EP-0255695-A2 | p-Hydroxycinnamamide derivatives and melanin inhibitor comprising the same | Kao Corporation (JP) | 1988-02-10 | — | — | EP | disclosed |
| EP-0255695-A2 | p-Hydroxycinnamamide derivatives and melanin inhibitor comprising the same | Kao Corporation (JP) | 1988-02-10 | — | — | EP | disclosed |
| EP-0255695-A2 | p-Hydroxycinnamamide derivatives and melanin inhibitor comprising the same | Kao Corporation (JP) | 1988-02-10 | — | — | EP | disclosed |
| JP-S60190713-A | MELANINE-SUPPRESSING AGENT | KAO CORP | 1985-09-28 | — | — | JP | disclosed |
| JP-S5746915-A | ANTIALLERGIC AGENT | BANYU PHARMACEUT CO LTD | 1982-03-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091612-A1 | PRINTING INTAGLIO PLATE AND PRODUCTION METHOD THEREOF, AND PRINTING METHOD | KIT, MC1R, LIFR | TYR 367/4885F3 1780/4885CYP2D6 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.